Guangdong Kanghua Healthcare Group 将来の成長

Future 基準チェック /06

現在、 Guangdong Kanghua Healthcare Groupの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare 収益成長	18.3%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly

Nov 25

There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings

Sep 30

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Jun 19

Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Jun 10

Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

May 22

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Nov 28

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

May 09

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Feb 02

Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Nov 08

Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Sep 06

Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

May 31

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Jan 25

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Sep 21

Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

May 03

Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

Feb 04

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

Dec 14

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Guangdong Kanghua Healthcare Group は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

SEHK:3689 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	2,039	51	93	190	N/A
3/31/2024	2,040	86	83	197	N/A
12/31/2023	2,042	121	73	204	N/A
9/30/2023	2,006	118	76	219	N/A
6/30/2023	1,970	115	80	234	N/A
3/31/2023	1,908	87	93	227	N/A
12/31/2022	1,846	60	106	221	N/A
9/30/2022	1,895	59	97	225	N/A
6/30/2022	1,945	59	87	228	N/A
3/31/2022	1,950	76	125	281	N/A
12/31/2021	1,954	94	162	333	N/A
9/30/2021	1,905	103	198	369	N/A
6/30/2021	1,856	112	233	405	N/A
3/31/2021	1,800	43	173	340	N/A
12/31/2020	1,745	-25	113	275	N/A
9/30/2020	1,774	-63	-8	167	N/A
6/30/2020	1,802	-100	-128	59	N/A
3/31/2020	1,879	-13	-124	78	N/A
12/31/2019	1,956	74	-121	98	N/A
9/30/2019	1,885	112	-29	153	N/A
6/30/2019	1,815	150	62	207	N/A
3/31/2019	1,727	159	74	192	N/A
12/31/2018	1,639	168	87	177	N/A
9/30/2018	1,566	169	73	181	N/A
6/30/2018	1,492	170	59	185	N/A
3/31/2018	1,441	163	N/A	200	N/A
12/31/2017	1,389	157	N/A	214	N/A
9/30/2017	1,338	153	N/A	189	N/A
6/30/2017	1,287	149	N/A	163	N/A
3/31/2017	1,264	145	N/A	159	N/A
12/31/2016	1,240	141	N/A	155	N/A
12/31/2015	1,064	119	N/A	199	N/A
12/31/2014	985	102	N/A	206	N/A
12/31/2013	859	107	N/A	214	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 3689の予測収益成長が貯蓄率 ( 2.3% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 3689の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 3689の収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 3689の収益がHong Kong市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: 3689の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 3689の自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Guangdong Kanghua Healthcare Group 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Here's Why Guangdong Kanghua Healthcare Group (HKG:3689) Can Manage Its Debt Responsibly

Investor sentiment deteriorates as stock falls 16%

There May Be Some Bright Spots In Guangdong Kanghua Healthcare Group's (HKG:3689) Earnings

First half 2024 earnings released: CN¥0.058 loss per share (vs CN¥0.15 profit in 1H 2023)

New minor risk - Profit margin trend

Guangdong Kanghua Healthcare Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Shareholders May Find It Hard To Justify Increasing Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) CEO Compensation For Now

Does Guangdong Kanghua Healthcare (HKG:3689) Deserve A Spot On Your Watchlist?

Guangdong Kanghua Healthcare Co., Ltd.'s (HKG:3689) Share Price Boosted 28% But Its Business Prospects Need A Lift Too

Investor sentiment improves as stock rises 19%

Full year 2023 earnings released: EPS: CN¥0.36 (vs CN¥0.18 in FY 2022)

Guangdong Kanghua Healthcare Co., Ltd., Annual General Meeting, Jun 26, 2024

Full year 2023 earnings released

Guangdong Kanghua Healthcare Co., Ltd. to Report Fiscal Year 2023 Results on Mar 28, 2024

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Investor sentiment improves as stock rises 33%

First half 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.012 loss in 1H 2022)

Guangdong Kanghua Healthcare Co., Ltd. to Report First Half, 2023 Results on Aug 31, 2023

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 22%

Now 24% undervalued after recent price drop

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Investor sentiment deteriorates as stock falls 16%

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Here's Why Guangdong Kanghua Healthcare (HKG:3689) Can Manage Its Debt Responsibly

Investor sentiment deteriorated over the past week

Some Investors May Be Worried About Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Investor sentiment deteriorated over the past week

First half 2022 earnings released: EPS: CN¥0 (vs CN¥0.092 in 1H 2021)

Guangdong Kanghua Healthcare Co., Ltd. to Report Q2, 2022 Results on Aug 30, 2022

Investor sentiment improved over the past week

Investors Could Be Concerned With Guangdong Kanghua Healthcare's (HKG:3689) Returns On Capital

Full year 2021 earnings released: EPS: CN¥0.28 (vs CN¥0.076 loss in FY 2020)

Guangdong Kanghua Healthcare Co., Ltd., Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Guangdong Kanghua Healthcare Co., Ltd. to Report Fiscal Year 2021 Final Results on Apr 14, 2022

Full year 2021 earnings released

Investor sentiment improved over the past week

Returns On Capital Signal Tricky Times Ahead For Guangdong Kanghua Healthcare (HKG:3689)

Investor sentiment improved over the past week

Capital Allocation Trends At Guangdong Kanghua Healthcare (HKG:3689) Aren't Ideal

First half 2021 earnings released: EPS CN¥0.092 (vs CN¥0.32 loss in 1H 2020)

Is Guangdong Kanghua Healthcare (HKG:3689) Using Too Much Debt?

Full year 2020 earnings released

Guangdong Kanghua Healthcare Co., Ltd. to Report Fiscal Year 2020 Results on Mar 29, 2021

Do Insiders Own Lots Of Shares In Guangdong Kanghua Healthcare Co., Ltd. (HKG:3689)?

New 90-day high: HK$3.50

Key Things To Understand About Guangdong Kanghua Healthcare's (HKG:3689) CEO Pay Cheque

New 90-day high: HK$3.20

New 90-day low: HK$2.51

First half earnings released

New 90-day low - HK$2.71

First half earnings released

New 90-day low - HK$2.76

Guangdong Kanghua Healthcare Co., Ltd. to Report First Half, 2020 Results on Aug 31, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘